JUNIPER PHARMACEUTICALS INC: 10-Q filed 2013-11-07
What JUNIPER PHARMACEUTICALS INC reported in its quarterly report filed 2013-11-07 (fiscal Q3 2013): 40 published measures, 111 facts as tagged in accession 0001193125-13-430479.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-11-07
- Fiscal period
- fiscal Q3 2013
- Accession
- 0001193125-13-430479 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All JUNIPER PHARMACEUTICALS INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 59,780,696 | USD | |
| At 2012-12-31 | 36,868,664 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 18,180,455 | USD | |
| At 2012-12-31 | 4,953,207 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 41,050,241 | USD | |
| At 2012-12-31 | 31,365,457 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 18,817,057 | USD | |
| At 2012-12-31 | 13,204,067 | USD | |
| At 2012-09-30 | 10,185,582 | USD | |
| At 2011-12-31 | 10,114,163 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -3,154,317 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 744,204 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 388,729 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 7,285,932 | USD | 274 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 4,915,475 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 1,252,020 | USD | 274 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 246,935 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 985,930 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | -17,659 | USD | 273 |
| 2012-01-01 to 2012-09-30 | -50,000 | USD | 274 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 590,512 | USD | 273 |
| 2012-01-01 to 2012-09-30 | -1,165,741 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | -247,621,276 | USD | |
| At 2012-12-31 | -248,365,480 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 11,137,780 | shares | 92 |
| 2013-01-01 to 2013-09-30 | 10,994,382 | shares | 273 |
| 2012-07-01 to 2012-09-30 | 10,916,358 | shares | 92 |
| 2012-01-01 to 2012-09-30 | 10,913,844 | shares | 274 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 11,137,780 | shares | 92 |
| 2013-01-01 to 2013-09-30 | 11,148,275 | shares | 273 |
| 2012-07-01 to 2012-09-30 | 11,067,853 | shares | 92 |
| 2012-01-01 to 2012-09-30 | 11,056,421 | shares | 274 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -0.28 | USD/shares | 92 |
| 2013-01-01 to 2013-09-30 | 0.07 | USD/shares | 273 |
| 2012-07-01 to 2012-09-30 | 0.04 | USD/shares | 92 |
| 2012-01-01 to 2012-09-30 | 0.67 | USD/shares | 274 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -0.28 | USD/shares | 92 |
| 2013-01-01 to 2013-09-30 | 0.07 | USD/shares | 273 |
| 2012-07-01 to 2012-09-30 | 0.04 | USD/shares | 92 |
| 2012-01-01 to 2012-09-30 | 0.17 | USD/shares | 274 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 2,624 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 8,174 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 2,342 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 5,018 | USD | 274 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 12,726,893 | USD | |
| At 2012-12-31 | 927,227 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 100,000 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 338,139 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 100,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 637,487 | USD | 274 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 1,267,275 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 5,108,325 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 1,440,571 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 1,848,385 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 31,368,613 | USD | |
| At 2012-12-31 | 35,902,555 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 6,557,935 | USD | |
| At 2012-12-31 | 3,745,934 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 2,556,163 | USD | |
| At 2012-12-31 | 1,435,660 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 15,560,287 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 6,848,148 | USD | |
| At 2012-12-31 | 1,159,145 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 2,620,202 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 7,400,359 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 2,045,675 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 7,233,106 | USD | 274 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 1,994,454 | USD | |
| At 2012-12-31 | 2,626,606 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 3,887,477 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 12,508,684 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 3,486,246 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 9,081,491 | USD | 274 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 3,238,215 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 8,910,550 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 3,186,792 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 9,655,624 | USD | 274 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 143,795 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 856,545 | USD | 274 |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 287,885,380 | USD | |
| At 2012-12-31 | 279,463,439 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 821,779 | USD | |
| At 2012-12-31 | 283,221 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 124,903 | USD | |
| At 2012-12-31 | 38,882 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 3,158,638 | USD | |
| At 2012-12-31 | 2,216,524 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 2,808,954 | USD | |
| At 2012-12-31 | 1,284,279 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -2,516,607 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 1,282,762 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 471,237 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 7,460,886 | USD | 274 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -3,147,442 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 723,579 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 388,729 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 7,285,932 | USD | 274 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 1,594,223 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 5,881,636 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 1,901,880 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 6,376,561 | USD | 274 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 25,195 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -57,165 | USD | 273 |
| 2012-07-01 to 2012-09-30 | -19,882 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -115,629 | USD | 274 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 2,026,081 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 308,865 | USD | 274 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | -635,400 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 938,288 | USD | 274 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 95,482 | USD | 273 |
| 2012-01-01 to 2012-09-30 | -856,417 | USD | 274 |
Inspect the source
- Entity
- JUNIPER PHARMACEUTICALS INC / CIK 0000821995
- Captured
- SEC response SHA-256
a3edd41c17929d04dd1a474f6ef2c35d05b3649e973c4fa27e448166db6cfbcf
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000821995.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))